Signal Advisors Wealth LLC lessened its holdings in Cigna Group (NYSE:CI – Free Report) by 46.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,927 shares of the health services provider’s stock after selling 2,566 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Cigna Group were worth $844,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Flaharty Asset Management LLC bought a new stake in Cigna Group in the first quarter valued at about $28,000. 1248 Management LLC acquired a new stake in Cigna Group during the first quarter valued at approximately $29,000. Solstein Capital LLC bought a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $29,000. Activest Wealth Management raised its holdings in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after buying an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC acquired a new position in shares of Cigna Group in the 2nd quarter worth approximately $30,000. 86.99% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts recently commented on the company. Robert W. Baird decreased their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Wolfe Research reduced their target price on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. Leerink Partners lowered their target price on shares of Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. The Goldman Sachs Group cut their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a report on Tuesday, November 4th. Finally, Jefferies Financial Group restated a “buy” rating and issued a $310.00 price target on shares of Cigna Group in a research report on Monday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $331.83.
Cigna Group Stock Down 0.7%
Shares of NYSE:CI opened at $272.11 on Friday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm has a market cap of $72.69 billion, a P/E ratio of 12.00, a P/E/G ratio of 0.99 and a beta of 0.26. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company’s 50-day moving average price is $277.41 and its two-hundred day moving average price is $292.67.
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the firm posted $7.51 earnings per share. The company’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.
Cigna Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were issued a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio is currently 26.64%.
Insiders Place Their Bets
In other news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO David Cordani purchased 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.70% of the stock is currently owned by company insiders.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories
- Five stocks we like better than Cigna Group
- The Significance of Brokerage Rankings in Stock Selection
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- Manufacturing Stocks Investing
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- What Investors Need to Know About Upcoming IPOs
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
